Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Design of the Diacerein Effect on Inflammatory Response in Patients With Covid-19: a Randomized, Placebo-controlled, Double-blind Trial.

NCT05226754 is registered in ClinicalTrials.gov with University of Campinas, Brazil as lead sponsor.

NCT NCT05226754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05226754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Design of the Diacerein Effect on Inflammatory Response in Patients With Covid-19: a Randomized, Placebo-controlled, Double-blind Trial.
Lead sponsor
University of Campinas, Brazil
Phase
Phase 2
Overall status
Unknown status
Start date
April 1, 2022
Completion date
July 8, 2023
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19